CINGULATE INC (CING) Fundamental Analysis & Valuation

NASDAQ:CING • US17248W3034

9.29 USD
+0.78 (+9.17%)
Last: Mar 12, 2026, 02:53 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CING fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

Taking everything into account, CING scores 1 out of 10 in our fundamental rating. CING was compared to 193 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of CING have multiple concerns. CING does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

0

1. CING Profitability Analysis

1.1 Basic Checks

  • In the past year CING has reported negative net income.
  • CING had a negative operating cash flow in the past year.
  • In the past 5 years CING always reported negative net income.
  • In the past 5 years CING always reported negative operating cash flow.
CING Yearly Net Income VS EBIT VS OCF VS FCFCING Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -5M -10M -15M -20M

1.2 Ratios

  • CING has a worse Return On Assets (-209.76%) than 88.08% of its industry peers.
  • With a Return On Equity value of -635.19%, CING is not doing good in the industry: 81.35% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -209.76%
ROE -635.19%
ROIC N/A
ROA(3y)-311.2%
ROA(5y)-229.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CING Yearly ROA, ROE, ROICCING Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

  • CING does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CING Yearly Profit, Operating, Gross MarginsCING Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CING Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for CING has been increased compared to 1 year ago.
  • CING has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CING has an improved debt to assets ratio.
CING Yearly Shares OutstandingCING Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
CING Yearly Total Debt VS Total AssetsCING Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

  • CING has an Altman-Z score of -17.45. This is a bad value and indicates that CING is not financially healthy and even has some risk of bankruptcy.
  • CING's Altman-Z score of -17.45 is on the low side compared to the rest of the industry. CING is outperformed by 80.83% of its industry peers.
  • A Debt/Equity ratio of 0.92 indicates that CING is somewhat dependend on debt financing.
  • The Debt to Equity ratio of CING (0.92) is worse than 70.98% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z -17.45
ROIC/WACCN/A
WACCN/A
CING Yearly LT Debt VS Equity VS FCFCING Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that CING should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, CING is doing worse than 75.13% of the companies in the same industry.
  • CING has a Quick Ratio of 1.26. This is a normal value and indicates that CING is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Quick ratio value of 1.26, CING is not doing good in the industry: 68.91% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
CING Yearly Current Assets VS Current LiabilitesCING Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. CING Growth Analysis

3.1 Past

  • CING shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 92.95%, which is quite impressive.
EPS 1Y (TTM)92.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.23%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • CING is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.80% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y77.93%
EPS Next 2Y38.17%
EPS Next 3Y25.25%
EPS Next 5Y21.8%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CING Yearly Revenue VS EstimatesCING Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2026 2027 2028 2029 2030 2031 2032 2033 100M 200M 300M
CING Yearly EPS VS EstimatesCING Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 -100 -200 -300

More info and screens

Find the best growth stocksShow best growing peers

1

4. CING Valuation Analysis

4.1 Price/Earnings Ratio

  • CING reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Also next year CING is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CING Price Earnings VS Forward Price EarningsCING Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CING Per share dataCING EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -2 -4 -6

4.3 Compensation for Growth

  • CING's earnings are expected to grow with 25.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.17%
EPS Next 3Y25.25%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CING Dividend Analysis

5.1 Amount

  • No dividends for CING!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

CING Fundamentals: All Metrics, Ratios and Statistics

CINGULATE INC

NASDAQ:CING (3/12/2026, 2:53:04 PM)

9.29

+0.78 (+9.17%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-13
Earnings (Next)N/A
Inst Owners6.71%
Inst Owner Change73.86%
Ins Owners0.12%
Ins Owner Change0.44%
Market Cap71.81M
Revenue(TTM)N/A
Net Income(TTM)-22.06M
Analysts82.22
Price Target29.84 (221.21%)
Short Float %5.45%
Short Ratio1.37
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-42.65%
Min EPS beat(2)-63.4%
Max EPS beat(2)-21.9%
EPS beat(4)0
Avg EPS beat(4)-64.58%
Min EPS beat(4)-171.8%
Max EPS beat(4)-1.2%
EPS beat(8)3
Avg EPS beat(8)-29.29%
EPS beat(12)4
Avg EPS beat(12)-23.4%
EPS beat(16)7
Avg EPS beat(16)-18.82%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.72%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.96%
EPS NY rev (1m)-42.99%
EPS NY rev (3m)-0.92%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 20.67
P/tB 20.67
EV/EBITDA N/A
EPS(TTM)-7.5
EYN/A
EPS(NY)-1.68
Fwd EYN/A
FCF(TTM)-2.32
FCFYN/A
OCF(TTM)-2.29
OCFYN/A
SpS0
BVpS0.45
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -209.76%
ROE -635.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-311.2%
ROA(5y)-229.62%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 35.28%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z -17.45
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)36.45%
Cap/Depr(5y)56.62%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)92.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%26.23%
EPS Next Y77.93%
EPS Next 2Y38.17%
EPS Next 3Y25.25%
EPS Next 5Y21.8%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-26.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-6.42%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.34%
OCF growth 3YN/A
OCF growth 5YN/A

CINGULATE INC / CING FAQ

Can you provide the ChartMill fundamental rating for CINGULATE INC?

ChartMill assigns a fundamental rating of 1 / 10 to CING.


What is the valuation status for CING stock?

ChartMill assigns a valuation rating of 1 / 10 to CINGULATE INC (CING). This can be considered as Overvalued.


How profitable is CINGULATE INC (CING) stock?

CINGULATE INC (CING) has a profitability rating of 0 / 10.


What is the financial health of CINGULATE INC (CING) stock?

The financial health rating of CINGULATE INC (CING) is 2 / 10.